Abiopharma

📋 Atlas Venture Fund XII, LP (Shareholder) plans to sell 9K shares of Disc Medicine, Inc. (at $93.60 each, total $887K) Filed: Dec 12, 2025 | ID: 056833

📋 Atlas Venture Opportunity Fund II, LP (Shareholder) plans to sell 12K shares of Disc Medicine, Inc. (at $93.60 each, total $1.2M) Filed: Dec 12, 2025 | ID: 056829

📋 Gruber James R. (Officer) plans to sell 5K shares of Eton Pharmaceuticals, Inc. (at $16.88 each, total $92K) Filed: Dec 12, 2025 | ID: 000479

Jonaitis Mark S. 🟡 adjusted position in 20.5K shares (3 derivative) of Varex Imaging Corp (VREX) at $11.70 Transaction Date: Dec 10, 2025 | Filing ID: 000127

New Form 424B3 - BioRestorative Therapies, Inc. Filed: 2025-12-12 AccNo: 0001021771-25-000152 Size: 167 KB

Hartmann Andrew 🟡 adjusted position in 22.4K shares (3 derivative) of Varex Imaging Corp (VREX) at $11.70 Transaction Date: Dec 10, 2025 | Filing ID: 000126

Director SANYAL SUNNY 🟡 adjusted position in 123.7K shares (3 derivative) of Varex Imaging Corp (VREX) at $11.70 Transaction Date: Dec 10, 2025 | Filing ID: 000125

Martinez Matthew Aaron 🟢 acquired 17.1K shares (1 derivative) of Varex Imaging Corp (VREX) Transaction Date: Dec 10, 2025 | Filing ID: 000124

Aranki Karen L 🟡 adjusted position in 20.0K shares (2 derivative) of Varex Imaging Corp (VREX) at $11.70 Transaction Date: Dec 10, 2025 | Filing ID: 000123

Maheshwari Shubham 🟡 adjusted position in 53.1K shares (3 derivative) of Varex Imaging Corp (VREX) at $11.70 Transaction Date: Dec 10, 2025 | Filing ID: 000122